Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 2300 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/12/94
End: 04/16/20
Due: 04/16/21
Phase: N/A
Priority: Normal
Start: 11/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 05/04/21
End: 10/22/21
Due: 10/22/22
Phase: N/A
Priority: Normal
Start: 09/09/15
End: 07/11/19
Due: 07/11/20
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 06/30/13
Due: 06/30/14
Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
Phase: N/A
Priority: Normal
Start: 04/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 08/10/23
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 07/31/94
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 04/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/19/91
End: 05/11/20
Due: 05/11/21
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 09/03/14
End: 06/15/15
Due: 06/15/16
Phase: N/A
Priority: Normal
Start: 11/17/08
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 04/05/19
End: 05/15/25
Due: 05/15/26
Phase: N/A
Priority: Normal
Start: 11/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/03
End: 09/30/08
Due: 09/30/09